{"hands_on_practices": [{"introduction": "Moving from theory to practice requires the ability to synthesize multiple clinical and radiological findings into a coherent diagnosis. This exercise challenges you to apply foundational principles of tumor biology to distinguish a benign osteochondroma from its malignant counterpart, a secondary peripheral chondrosarcoma. By evaluating features like cartilage cap thickness and growth patterns, you will hone the critical reasoning skills used in everyday pathology to assess the risk of malignancy [@problem_id:4417134].", "problem": "A cartilage-capped bony projection continuous with the cortex and medullary cavity of the host bone is classically termed an osteochondroma. A secondary peripheral chondrosarcoma arises when the cartilage cap of an osteochondroma undergoes malignant transformation. Use the following foundational principles and well-tested observations to reason about their contrasting features: (i) benign lesions typically show circumscribed growth without invasion of adjacent tissue compartments, whereas malignant lesions demonstrate infiltrative behavior that violates normal boundaries; (ii) endochondral and appositional cartilage growth associated with the physis ceases at skeletal maturity, so benign physeal-related lesions should not continue to enlarge after maturity; (iii) Magnetic Resonance Imaging (MRI) can reliably measure cartilage cap thickness, and malignant transformation in adults often correlates with a markedly thickened cap; (iv) infiltrative growth into medullary spaces (marrow permeation) reflects malignancy; (v) clinically, pain that newly appears or progresses after skeletal maturity suggests ongoing growth and potential malignant transformation, whereas benign osteochondromas tend to be asymptomatic or have mechanical irritation that stabilizes once growth stops.\n\nWhich option best contrasts osteochondroma with secondary peripheral chondrosarcoma across the four domains: cartilage cap thickness, cap lobulation, marrow permeation, and pain progression after skeletal maturity?\n\nA. Osteochondroma typically has a thin cartilage cap in adults (commonly $<1.5\\,\\mathrm{cm}$), with a smooth to mildly lobulated contour, no permeative invasion of adjacent marrow, and pain that stabilizes or improves after skeletal maturity; secondary peripheral chondrosarcoma commonly has a thick cartilage cap in adults (often $>2\\,\\mathrm{cm}$), coarsely lobulated/nodular morphology, marrow permeation into the stalk and adjacent bone, and new or progressive pain after maturity.\n\nB. Osteochondroma commonly has a thick adult cartilage cap (frequently $>2\\,\\mathrm{cm}$) with irregular lobulation, while secondary peripheral chondrosarcoma has a thin cap ($<1\\,\\mathrm{cm}$), decreasing pain after maturity, and no marrow permeation.\n\nC. Osteochondroma lacks medullary continuity with the host bone, whereas secondary peripheral chondrosarcoma shows medullary continuity and marrow permeation, and pain is unchanged after maturity in both.\n\nD. Cartilage cap thickness is variable and not clinically informative in differentiating osteochondroma from secondary peripheral chondrosarcoma; lobulation alone is the discriminator, marrow permeation may be present in either, and pain progression after maturity is not a reliable indicator.\n\nE. Osteochondroma has a thin cap but can show marrow permeation via medullary continuity, while secondary peripheral chondrosarcoma has a thick cap but no marrow permeation, and pain progression after maturity is typically absent.", "solution": "The problem statement is subjected to validation before a solution is attempted.\n\n### Step 1: Extract Givens\nThe problem provides the following definitions and principles:\n- **Osteochondroma:** A cartilage-capped bony projection continuous with the cortex and medullary cavity of the host bone.\n- **Secondary Peripheral Chondrosarcoma:** Arises from malignant transformation of the cartilage cap of an osteochondroma.\n- **Principle (i):** Benign lesions exhibit circumscribed growth without tissue invasion; malignant lesions are infiltrative.\n- **Principle (ii):** Benign physeal-related lesions, such as osteochondromas, should cease to enlarge after skeletal maturity, as the underlying cartilage growth mechanisms stop.\n- **Principle (iii):** Magnetic Resonance Imaging (MRI) can measure cartilage cap thickness, and malignant transformation in adults is often correlated with a markedly thickened cap.\n- **Principle (iv):** Infiltrative growth into medullary spaces (marrow permeation) is a sign of malignancy.\n- **Principle (v):** New or progressive pain after skeletal maturity suggests ongoing growth and potential malignant transformation. Benign osteochondromas are typically asymptomatic or have stable, non-progressive symptoms after maturity.\n- **Question:** The task is to identify the option that best contrasts osteochondroma and secondary peripheral chondrosarcoma across four features: cartilage cap thickness, cap lobulation, marrow permeation, and pain progression after skeletal maturity.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement is evaluated for validity.\n- **Scientifically Grounded:** The problem is based on established principles of musculoskeletal pathology and oncology. The descriptions of osteochondroma, secondary chondrosarcoma, and the criteria differentiating benign from malignant lesions (growth pattern, cessation of growth, imaging features, clinical symptoms) are all factually correct and fundamental to the field.\n- **Well-Posed:** The problem provides a sufficient set of principles to logically deduce the contrasting features of the two entities. The question is clear and directs the solver to a specific comparison. A unique best answer can be determined by applying the given principles.\n- **Objective:** The language is clinical and precise, free from subjective or ambiguous terminology. The principles are presented as \"foundational\" and \"well-tested,\" which is appropriate for a problem of this nature.\n\n### Step 3: Verdict and Action\nThe problem statement is **valid**. It is scientifically sound, well-posed, objective, and self-contained. Therefore, a solution will be derived by applying the provided principles.\n\n### Derivation of Contrasting Features\nBased on the provided principles, we can deduce the expected characteristics for each entity in an adult after skeletal maturity.\n\n1.  **Cartilage Cap Thickness:**\n    -   **Osteochondroma (Benign):** According to principle (ii), its growth ceases at skeletal maturity. Therefore, the cartilage cap, the source of growth, is expected to become inactive and thin.\n    -   **Secondary Peripheral Chondrosarcoma (Malignant):** According to principle (iii), malignant transformation is associated with a markedly thickened cap, reflecting renewed and uncontrolled proliferation of cartilage.\n\n2.  **Cap Lobulation:**\n    -   **Osteochondroma (Benign):** Principle (i) states that benign lesions have circumscribed growth. This typically results in a smooth or, at most, mildly lobulated surface contour.\n    -   **Secondary Peripheral Chondrosarcoma (Malignant):** Principle (i) describes malignant lesions as having infiltrative behavior. This uncontrolled growth often leads to a more disorganized, coarsely lobulated or nodular morphology.\n\n3.  **Marrow Permeation:**\n    -   **Osteochondroma (Benign):** By its definition, it has continuity with the medullary cavity, but this is a structural feature, not an invasive one. Principle (i) explicitly states that benign lesions do not invade adjacent tissues. Thus, there is no *infiltrative permeation* of the marrow.\n    -   **Secondary Peripheral Chondrosarcoma (Malignant):** Principle (iv) directly states that marrow permeation (infiltrative growth into medullary spaces) reflects malignancy. The malignant cells would invade the bony stalk of the osteochondroma and potentially the adjacent host bone.\n\n4.  **Pain Progression After Skeletal Maturity:**\n    -   **Osteochondroma (Benign):** Principle (v) indicates that after skeletal maturity, pain, if present (e.g., from mechanical irritation), should stabilize or improve, as the lesion is no longer growing.\n    -   **Secondary Peripheral Chondrosarcoma (Malignant):** Principle (v) notes that new or progressive pain after skeletal maturity is a key symptom suggesting ongoing growth and malignant transformation.\n\n### Option-by-Option Analysis\n\n**A. Osteochondroma typically has a thin cartilage cap in adults (commonly $<1.5\\,\\mathrm{cm}$), with a smooth to mildly lobulated contour, no permeative invasion of adjacent marrow, and pain that stabilizes or improves after skeletal maturity; secondary peripheral chondrosarcoma commonly has a thick cartilage cap in adults (often $>2\\,\\mathrm{cm}$), coarsely lobulated/nodular morphology, marrow permeation into the stalk and adjacent bone, and new or progressive pain after maturity.**\n- This option accurately reflects all four points of contrast derived from the principles. The osteochondroma is described as having a thin cap, mild lobulation, no marrow permeation, and stable pain. The chondrosarcoma is described with a thick cap, coarse lobulation, marrow permeation, and progressive pain. The numerical values of $<1.5\\,\\mathrm{cm}$ and $>2\\,\\mathrm{cm}$ are clinically accepted thresholds that are consistent with the qualitative principles of \"thin\" versus \"markedly thickened.\"\n- **Verdict: Correct.**\n\n**B. Osteochondroma commonly has a thick adult cartilage cap (frequently $>2\\,\\mathrm{cm}$) with irregular lobulation, while secondary peripheral chondrosarcoma has a thin cap ($<1\\,\\mathrm{cm}$), decreasing pain after maturity, and no marrow permeation.**\n- This option incorrectly reverses the key features. It assigns the features of a malignant lesion (thick cap) to the benign osteochondroma and the features of a benign lesion (thin cap, decreasing pain, no permeation) to the malignant chondrosarcoma. This contradicts principles (ii), (iii), (iv), and (v).\n- **Verdict: Incorrect.**\n\n**C. Osteochondroma lacks medullary continuity with the host bone, whereas secondary peripheral chondrosarcoma shows medullary continuity and marrow permeation, and pain is unchanged after maturity in both.**\n- This option begins with a statement that \"Osteochondroma lacks medullary continuity,\" which directly contradicts the definition provided in the problem statement (\"continuous with the... medullary cavity of the host bone\"). It also incorrectly states that pain is unchanged in chondrosarcoma, contradicting principle (v).\n- **Verdict: Incorrect.**\n\n**D. Cartilage cap thickness is variable and not clinically informative in differentiating osteochondroma from secondary peripheral chondrosarcoma; lobulation alone is the discriminator, marrow permeation may be present in either, and pain progression after maturity is not a reliable indicator.**\n- This option systematically negates the given principles. It claims cap thickness is not informative (contradicts principle iii), that marrow permeation can be in either (contradicts principle iv), and that pain progression is unreliable (contradicts principle v). It incorrectly dismisses multiple key diagnostic criteria.\n- **Verdict: Incorrect.**\n\n**E. Osteochondroma has a thin cap but can show marrow permeation via medullary continuity, while secondary peripheral chondrosarcoma has a thick cap but no marrow permeation, and pain progression after maturity is typically absent.**\n- This option incorrectly equates \"medullary continuity\" with \"marrow permeation\" for the benign lesion, which is a misunderstanding of a structural feature versus an infiltrative process (violates principles i and iv). It incorrectly states that chondrosarcoma has no marrow permeation (violates principle iv) and that pain progression is absent (violates principle v).\n- **Verdict: Incorrect.**\n\nBased on the rigorous application of the provided principles, option A is the only one that correctly and comprehensively contrasts the features of a benign osteochondroma with its malignant transformation into a secondary peripheral chondrosarcoma.", "answer": "$$\\boxed{A}$$", "id": "4417134"}, {"introduction": "A key radiological sign suggesting malignancy in an osteochondroma is a thickened cartilage cap, but how powerful is this indicator on its own? This practice shifts our focus from qualitative features to quantitative evaluation by applying biostatistics to a clinical scenario. You will calculate the positive predictive value ($PPV$) of this finding, a crucial exercise that demonstrates how the reliability of a diagnostic test is fundamentally linked to the prevalence of the disease in the population being tested [@problem_id:4417202].", "problem": "A radiology-pathology correlation study of osteochondroma in adults evaluates malignant transformation to secondary chondrosarcoma using Magnetic Resonance Imaging (MRI). Define a diagnostic test as positive if the cartilage cap thickness is greater than $2$ centimeters. In a referred adult cohort, this test has sensitivity $Se=0.85$ and specificity $Sp=0.90$, and the prevalence of malignant transformation is $P=0.05$. Using the standard definitions of sensitivity, specificity, prevalence, and Bayes theorem, compute the positive predictive value $PPV$, defined as the probability that a lesion is malignant given a positive test. Express your final answer as a decimal and round to four significant figures. Do not use a percentage sign.", "solution": "The problem is subjected to validation before a solution is attempted.\n\n### Step 1: Extract Givens\n- Diagnostic test is positive if cartilage cap thickness is greater than $2$ centimeters.\n- Sensitivity: $Se = 0.85$\n- Specificity: $Sp = 0.90$\n- Prevalence of malignant transformation: $P = 0.05$\n- Task: Compute the positive predictive value, $PPV$.\n- Final answer format: Decimal rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is evaluated against the specified criteria.\n- **Scientifically Grounded**: The problem utilizes established concepts from epidemiology and biostatistics, namely sensitivity, specificity, prevalence, and positive predictive value. These are applied to a medically realistic scenario: the radiological evaluation of osteochondroma for malignant transformation, where cartilage cap thickness is a recognized diagnostic criterion. The provided numerical values for $Se$, $Sp$, and $P$ are plausible within a clinical context. The problem is scientifically sound.\n- **Well-Posed**: The problem provides all necessary data ($Se$, $Sp$, $P$) for the calculation of the requested quantity ($PPV$). The relationship between these variables is governed by Bayes' theorem, which guarantees the existence of a unique, stable, and meaningful solution.\n- **Objective**: The problem is stated using precise, unambiguous, and objective language.\n- **Conclusion**: The problem does not violate any of the invalidity criteria. It is self-contained, consistent, and scientifically grounded.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. A full solution will be derived.\n\n### Solution Derivation\nLet $M$ denote the event that a lesion is malignant (disease present), and let $B$ denote the event that the lesion is benign (disease absent). Let $T^+$ denote a positive test result, and $T^-$ denote a negative test result.\n\nThe information provided can be formally expressed as probabilities:\nThe prevalence of malignant transformation is the prior probability of the disease, $P(M)$.\n$$P(M) = 0.05$$\nThe probability of a lesion being benign is the complement of it being malignant.\n$$P(B) = 1 - P(M) = 1 - 0.05 = 0.95$$\nSensitivity is the probability of a positive test given that the disease is present.\n$$Se = P(T^+ | M) = 0.85$$\nSpecificity is the probability of a negative test given that the disease is absent.\n$$Sp = P(T^- | B) = 0.90$$\n\nThe objective is to calculate the positive predictive value ($PPV$), which is the probability that a lesion is malignant given a positive test result. This is the conditional probability $P(M | T^+)$.\n\nAccording to Bayes' theorem, the $PPV$ is given by:\n$$PPV = P(M | T^+) = \\frac{P(T^+ | M) P(M)}{P(T^+)}$$\n\nThe denominator, $P(T^+)$, is the total probability of a positive test. This can be calculated using the law of total probability, summing over the two mutually exclusive scenarios in which a positive test can occur: a true positive (the lesion is malignant and the test is positive) and a false positive (the lesion is benign and the test is positive).\n$$P(T^+) = P(T^+ \\cap M) + P(T^+ \\cap B)$$\nUsing the definition of conditional probability, $P(A \\cap C) = P(A|C)P(C)$, this can be expanded as:\n$$P(T^+) = P(T^+ | M) P(M) + P(T^+ | B) P(B)$$\n\nThe term $P(T^+|B)$ is the false positive rate. It is the complement of the specificity, $Sp = P(T^-|B)$, since for a given condition (disease absent), the test can only be positive or negative.\n$$P(T^+ | B) = 1 - P(T^- | B) = 1 - Sp$$\nSubstituting the given value for specificity:\n$$P(T^+ | B) = 1 - 0.90 = 0.10$$\n\nNow, we can compute the value of $P(T^+)$:\n$$P(T^+) = (P(T^+ | M) \\times P(M)) + (P(T^+ | B) \\times P(B))$$\n$$P(T^+) = (0.85 \\times 0.05) + (0.10 \\times 0.95)$$\n$$P(T^+) = 0.0425 + 0.095$$\n$$P(T^+) = 0.1375$$\n\nFinally, substitute the known values back into the Bayes' theorem formula for $PPV$:\n$$PPV = P(M | T^+) = \\frac{P(T^+ | M) P(M)}{P(T^+)}$$\n$$PPV = \\frac{0.85 \\times 0.05}{0.1375}$$\n$$PPV = \\frac{0.0425}{0.1375}$$\n$$PPV \\approx 0.30909090...$$\n\nThe problem requires the answer to be rounded to four significant figures.\n$$PPV \\approx 0.3091$$", "answer": "$$\\boxed{0.3091}$$", "id": "4417202"}, {"introduction": "Clinical guidelines often rely on sharp numerical thresholds, but medical measurements are rarely perfectly precise. This final practice explores the real-world impact of measurement uncertainty on diagnostic decision-making. By modeling the error inherent in MRI measurements, you will quantify the probability of diagnostic errors—false positives and false negatives—especially when a true measurement lies near a clinical cutoff, providing a deeper appreciation for the probabilistic nature of diagnosis [@problem_id:4417136].", "problem": "You are tasked with designing a program to quantify how measurement error in Magnetic Resonance Imaging (MRI) of cartilage cap thickness for osteochondroma affects threshold-based decision making. In pathology, an osteochondroma with a cartilage cap thicker than a certain threshold is suspicious for malignant transformation to chondrosarcoma. For adults, the commonly used threshold is $2.0$ centimeters, and for children the commonly used threshold is $3.0$ centimeters. All thickness quantities in this problem must be treated in centimeters and expressed as decimals (not percentages). No angle quantities are involved.\n\nUse the following fundamental base:\n- Measurement model: the measured value $M$ equals the true value $T$ plus an error $E$, written as $M = T + E$.\n- The measurement error $E$ is modeled as a Normal (Gaussian) random variable with mean $0$ and standard deviation $\\sigma$, noted $E \\sim \\mathcal{N}(0,\\sigma^{2})$.\n- For this problem, use $\\sigma = 0.2$ centimeters.\n- The decision rule is threshold-based: classify as “suspicious” (positive) if the measured thickness $M$ exceeds a threshold $\\tau$; otherwise classify as “not suspicious” (negative). Formally, the measured classification is positive if $M > \\tau$ and negative otherwise.\n- The ground truth classification is determined by the true value $T$ using the same threshold rule: ground truth positive if $T > \\tau$ and ground truth negative otherwise.\n\nFrom these fundamentals, derive expressions for:\n1. The probability of a measured positive given the true value $T = t$ and threshold $\\tau$, denoted $\\mathbb{P}(\\text{measured positive} \\mid T = t, \\tau)$.\n2. The false positive probability for a case with true value $T = t$ and threshold $\\tau$, defined as the probability that the measured classification is positive while the ground truth classification is negative.\n3. The false negative probability for a case with true value $T = t$ and threshold $\\tau$, defined as the probability that the measured classification is negative while the ground truth classification is positive.\n\nYour program should implement these derived expressions and evaluate them for the following test suite of cases (all thicknesses and thresholds in centimeters):\n- Case A (adult, near-below threshold): $t = 1.8$, $\\tau = 2.0$.\n- Case B (adult, boundary at threshold): $t = 2.0$, $\\tau = 2.0$.\n- Case C (adult, above threshold): $t = 2.5$, $\\tau = 2.0$.\n- Case D (child, near-below threshold): $t = 2.9$, $\\tau = 3.0$.\n- Case E (child, above threshold): $t = 3.4$, $\\tau = 3.0$.\n\nFor each case, your program must output a list of three decimal values:\n- The probability of measured positive $\\mathbb{P}(\\text{measured positive} \\mid T = t, \\tau)$.\n- The false positive probability (use the ground truth determined by $T$ and $\\tau$).\n- The false negative probability (use the ground truth determined by $T$ and $\\tau$).\n\nYour program should produce a single line of output containing the results as a comma-separated list enclosed in square brackets, where each element is itself a list of the three values for the corresponding case, in the order A, B, C, D, E. For example, an output of the correct format would look like:\n$[\\,[p_{A},fp_{A},fn_{A}],\\,[p_{B},fp_{B},fn_{B}],\\ldots\\ ]$\nAll numerical answers must be expressed as unitless decimal floats (implicitly in centimeters through the modeling) and not as percentages. No angles are used, so there is no angle unit requirement.", "solution": "The user-provided problem has been analyzed and is determined to be valid. It is scientifically grounded, well-posed, objective, and contains all necessary information to derive a unique, meaningful solution. We may therefore proceed with the derivation and implementation.\n\nThe core of this problem is to quantify the uncertainty in a clinical decision that is based on a measured value subject to random error. We are given a measurement model, an error distribution, and a decision rule. Our task is to derive the probabilities of specific outcomes and classification errors.\n\nLet $T$ be the true thickness of the cartilage cap and $M$ be the measured thickness. All quantities are in centimeters. The relationship between them is given by the model:\n$$\nM = T + E\n$$\nwhere $E$ is the measurement error. The error $E$ is modeled as a random variable following a Normal (Gaussian) distribution with a mean of $0$ and a standard deviation of $\\sigma$. This is denoted as $E \\sim \\mathcal{N}(0, \\sigma^2)$. For this problem, we are given $\\sigma = 0.2$ cm.\n\nFor a specific case where the true thickness is a known value $T=t$, the measured thickness $M$ becomes a random variable. Its distribution is derived from the model:\n$$\nM = t + E\n$$\nSince $E \\sim \\mathcal{N}(0, \\sigma^2)$, and $t$ is a constant, $M$ is also normally distributed. The mean of $M$ is $\\mathbb{E}[M] = \\mathbb{E}[t+E] = t + \\mathbb{E}[E] = t+0 = t$. The variance of $M$ is $\\text{Var}(M) = \\text{Var}(t+E) = \\text{Var}(E) = \\sigma^2$.\nThus, the distribution of the measured value, given a true value $t$, is:\n$$\nM \\sim \\mathcal{N}(t, \\sigma^2)\n$$\n\nThe decision rule is based on a threshold $\\tau$. The classification is \"suspicious\" (positive) if the thickness exceeds $\\tau$, and \"not suspicious\" (negative) otherwise.\n- Measured classification is positive if $M > \\tau$.\n- Ground truth classification is positive if $T > \\tau$.\n\nWe will now derive the expressions for the three required probabilities for a given true value $T=t$ and threshold $\\tau$.\n\n1.  **Probability of a measured positive, $\\mathbb{P}(\\text{measured positive} \\mid T = t, \\tau)$**\n    This is the probability that the measured value $M$ exceeds the threshold $\\tau$, given that the true value is $t$.\n    $$\n    \\mathbb{P}(\\text{measured positive} \\mid T = t, \\tau) = \\mathbb{P}(M > \\tau)\n    $$\n    To calculate this probability, we standardize the random variable $M$. We define a standard normal variable $Z = \\frac{M - t}{\\sigma}$, where $Z \\sim \\mathcal{N}(0, 1)$.\n    The inequality $M > \\tau$ can be rewritten in terms of $Z$:\n    $$\n    M - t > \\tau - t \\implies \\frac{M - t}{\\sigma} > \\frac{\\tau - t}{\\sigma} \\implies Z > \\frac{\\tau - t}{\\sigma}\n    $$\n    The probability is then expressed using the cumulative distribution function (CDF) of the standard normal distribution, $\\Phi(z) = \\mathbb{P}(Z \\le z)$. The probability of $Z$ exceeding a value is given by the survival function (SF), which is $1 - \\Phi(z)$.\n    $$\n    \\mathbb{P}(\\text{measured positive}) = \\mathbb{P}\\left(Z > \\frac{\\tau - t}{\\sigma}\\right) = 1 - \\Phi\\left(\\frac{\\tau - t}{\\sigma}\\right)\n    $$\n\n2.  **False Positive Probability**\n    A false positive occurs when the measured classification is positive ($M > \\tau$) but the ground truth classification is negative ($T \\le \\tau$).\n    We are calculating this for a specific true value $T=t$.\n    - If the ground truth is positive (i.e., $t > \\tau$), a false positive is impossible by definition. In this scenario, the false positive probability is $0$.\n    - If the ground truth is negative (i.e., $t \\le \\tau$), then a false positive occurs if the measurement is positive ($M > \\tau$). The probability of this event is exactly the probability of a measured positive we calculated above.\n    Therefore, the false positive probability, $P_{FP}$, is:\n    $$\n    P_{FP}(t, \\tau) = \\begin{cases} \\mathbb{P}(M > \\tau) = 1 - \\Phi\\left(\\frac{\\tau - t}{\\sigma}\\right) & \\text{if } t \\le \\tau \\\\ 0 & \\text{if } t > \\tau \\end{cases}\n    $$\n\n3.  **False Negative Probability**\n    A false negative occurs when the measured classification is negative ($M \\le \\tau$) but the ground truth classification is positive ($T > \\tau$).\n    Again, we consider the specific true value $T=t$.\n    - If the ground truth is negative (i.e., $t \\le \\tau$), a false negative is impossible. The false negative probability is $0$.\n    - If the ground truth is positive (i.e., $t > \\tau$), then a false negative occurs if the measurement is negative ($M \\le \\tau$). The probability for this is $\\mathbb{P}(M \\le \\tau)$.\n    Using the same standardization as before:\n    $$\n    \\mathbb{P}(M \\le \\tau) = \\mathbb{P}\\left(Z \\le \\frac{\\tau - t}{\\sigma}\\right) = \\Phi\\left(\\frac{\\tau - t}{\\sigma}\\right)\n    $$\n    Therefore, the false negative probability, $P_{FN}$, is:\n    $$\n    P_{FN}(t, \\tau) = \\begin{cases} \\mathbb{P}(M \\le \\tau) = \\Phi\\left(\\frac{\\tau - t}{\\sigma}\\right) & \\text{if } t > \\tau \\\\ 0 & \\text{if } t \\le \\tau \\end{cases}\n    $$\n\nThese derived formulae are implemented in the provided Python program. The program uses the `scipy.stats.norm` library, where `norm.sf` corresponds to the survival function $1-\\Phi$ and `norm.cdf` corresponds to the cumulative distribution function $\\Phi$. The `loc` parameter represents the mean ($t$) and the `scale` parameter represents the standard deviation ($\\sigma$).", "answer": "```python\n# The complete and runnable Python 3 code goes here.\n# Imports must adhere to the specified execution environment.\nimport numpy as np\nfrom scipy.stats import norm\n\ndef solve():\n    \"\"\"\n    Calculates probabilities related to MRI measurement error for osteochondroma\n    cartilage cap thickness.\n    \"\"\"\n\n    # Define the constant standard deviation of the measurement error.\n    # All units are in centimeters.\n    sigma = 0.2\n\n    # Define the test cases from the problem statement.\n    # Each case is a tuple: (true_thickness_t, threshold_tau).\n    test_cases = [\n        # Case A (adult, near-below threshold)\n        (1.8, 2.0),\n        # Case B (adult, boundary at threshold)\n        (2.0, 2.0),\n        # Case C (adult, above threshold)\n        (2.5, 2.0),\n        # Case D (child, near-below threshold)\n        (2.9, 3.0),\n        # Case E (child, above threshold)\n        (3.4, 3.0),\n    ]\n\n    def calculate_metrics(t, tau, sigma_val):\n        \"\"\"\n        Calculates the required probabilities for a single case.\n\n        The measurement M is modeled as a normal random variable M ~ N(t, sigma^2).\n\n        Args:\n            t (float): The true thickness.\n            tau (float): The decision threshold.\n            sigma_val (float): The standard deviation of the measurement error.\n\n        Returns:\n            list: A list containing:\n                  - Probability of measured positive.\n                  - False positive probability.\n                  - False negative probability.\n        \"\"\"\n        # P(measured positive) = P(M > tau)\n        # We use the survival function (1 - CDF) of the normal distribution.\n        # The distribution of M is N(loc=t, scale=sigma_val).\n        p_positive = norm.sf(tau, loc=t, scale=sigma_val)\n\n        # P(measured negative) = P(M <= tau)\n        # We use the cumulative distribution function (CDF).\n        p_negative = norm.cdf(tau, loc=t, scale=sigma_val)\n\n        # Determine the ground truth classification.\n        # Ground truth is positive if t > tau.\n        is_true_positive = t > tau\n\n        # A false positive occurs when the measurement is positive (M > tau)\n        # but the ground truth is negative (t <= tau).\n        # This can only happen if the ground truth is negative.\n        fp_prob = p_positive if not is_true_positive else 0.0\n\n        # A false negative occurs when the measurement is negative (M <= tau)\n        # but the ground truth is positive (t > tau).\n        # This can only happen if the ground truth is positive.\n        fn_prob = p_negative if is_true_positive else 0.0\n\n        return [p_positive, fp_prob, fn_prob]\n\n    results = []\n    for t_case, tau_case in test_cases:\n        # Calculate the three metrics for the current test case.\n        metrics = calculate_metrics(t_case, tau_case, sigma)\n        results.append(metrics)\n\n    # Format the final output string as specified.\n    # Each inner list is converted to a string with comma-separated values,\n    # and these strings are then joined by commas.\n    # Example: \"[[val1,val2],[val3,val4]]\"\n    inner_results_str = [f\"[{','.join(map(str, res))}]\" for res in results]\n    final_output_str = f\"[{','.join(inner_results_str)}]\"\n    \n    # Final print statement in the exact required format.\n    print(final_output_str)\n\nsolve()\n```", "id": "4417136"}]}